General Electric Moves Closer to Outright Breakup
GE has completed its strategic review and announced the conglomerate's path forward, including spinning off its health care unit.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 131
Epilepsy Treatment Derived From Marijuana Approved for US Sales
GW Pharmaceuticals on Monday received approval from the U.S. FDA for its epilepsy drug derived from the marijuana plant. This is the first drug of its kind to receive FDA approval.
Why Merrimack Pharmaceuticals Is Getting Crushed
Merrimack Pharmaceuticals shares were absolutely getting crushed on Monday after the firm gave an update from its midstage pancreatic cancer study.
Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer
Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was looking for.
Biopharma Companies to Watch This Week
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Tandem Diabetes Keeps Rolling Out the Hits
Tandem Diabetes Care shares made a solid gain early on Friday after the firm announced a key approval from the FDA.
Why Everything Is Going Right for Heron Therapeutics
Heron Therapeutics shares made a massive gain on Thursday after the company announced a few key developments.
Is Voyager Therapeutics Poised to Win Big With Parkinson’s Treatment?
For many drug developers, Parkinson’s disease is a tricky disease to treat. However, developing a treatment ultimately could yield a huge reward as there are currently no therapies that effectively slow or reverse the…
The Search Is Over: JPMorgan, Amazon and Berkshire Hathaway Find CEO to Head Up Health Care Firm
Amazon.com, JPMorgan and Berkshire Hathaway are now making their combined health care plan a reality with the appointment of a new chief executive officer.
Why Sarepta Shares Are Skyrocketing
Sarepta Therapeutics shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy trial.
Are FMI Shareholders Getting Enough in the Roche Acquisition?
Foundation Medicine shares saw a sizable jump early on Tuesday after the company announced that Roche would be acquiring all of the outstanding shares.
Fewer Americans Than Ever Are Smokers
Fewer Americans than ever are smoking, according to data released Tuesday by the Centers for Disease Control. Just under 14% of U.S. adults still smoke.
Forty Seven Announces Potential Pricing for IPO
Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued up to more than $123 million.
Why PTC Therapeutics Shares Are Booming
PTC Therapeutics watched its shares make a massive gain early on Monday after the firm presented updated preliminary results from its study investigating risdiplam in babies with spinal muscular atrophy.
FDA Lifts Clinical Hold on Solid Biosciences
Solid Biosciences watched its shares surge to kick off the week after the FDA lifted the clinical hold on its treatment for Duchenne muscular dystrophy.